Read our previous insight-driven newsletters covering business, finance, economics and tech.
Plus: Is Novo Nordisk becoming a victim of its own incredible success?
Plus: IBM’s Risk Analysis; Meta’s Tracking Ring
Plus: Franklin Templeton is all-in on alts.
Plus: Why dealmakers are giddy.
Plus: Can Nintendo keep playing by Mushroom Kingdom rules?
Plus, more women say they’re CFOs of the household.
Plus: Big Tech wants nukes now. Regulators say not so fast.
Plus: Tesla Boosts Data; Baidu Paints a Picture